Triglyceride-glucose body mass index

There are 70 papers on triglyceride-glucose body mass index in aging research: 1 trial and 66 observational studies in people, 3 reviews.

Biomarker

70 papers study it6 more mention it66 findings

16 new papers in 30 daysSee all 76 papers on triglyceride-glucose body mass index

At a glance

Higher triglyceride-glucose body mass index is linked with early vascular aging, sarcopenia and cardiovascular disease in human observational studies. Mortality associations run in both directions: in women, higher values are linked with lower mortality below a threshold and higher mortality above it, while US adults with periodontitis show no clear link.

66 findings in 47 papers from 2022 to 2026, 20 of them since May 2026

“The highest quartiles of TyG, TyG-BMI, TyG-WC, TyG-WHtR, and TyG-WHR were significantly associated with increased breast cancer risk”
Triglyceride glucose related indices predict incident breast cancer risk in a population based cohort studyDiscover oncology2025doi:10.1007/s12672-025-04031-8
  • Human trial1
  • Humans66

Effects

2

Mortality

no changein humans2

2 studies
  1. Triglyceride-glucose body mass index was not clearly linked with mortality in US adults with periodontitis.

    “Triglyceride-glucose-body mass index was not significantly associated with all-cause, cardiovascular disease-related, or cancer-related mortality.”

    Humansin US adults with periodontitis

    Association between triglyceride-glucose-related indices and all-cause and cause-specific mortality among individuals with periodontitis: A population-based study

    The Journal of international medical research

  2. Triglyceride-glucose body mass index was not clearly linked with mortality in humans (critically ill older adults with ASCVD) (P = 0.883).

    “whereas TyG-BMI was not significantly associated with mortality (P = 0.883).”

    Humanscritically ill older adults with ASCVD90-dayn = 2,368

    Comparative prognostic value of TyG index and TyG-BMI for 90-day all-cause mortality in critically ill older adults with ASCVD: a machine learning analysis of the MIMIC-IV database

    Cardiovascular diabetology

Ultrasound-defined diastolic dysfunction

no changein humans1OR 1.35

1 study
  1. Triglyceride-glucose body mass index was not clearly linked with ultrasound-defined diastolic dysfunction in humans (Fully adjusted continuous analysis, per 1-standard deviation increase) (OR 1.35, 95% CI 0.42–4.40; P = 0.616).

    “each 1-standard deviation increase was not significantly associated with ultrasound-defined diastolic dysfunction in continuous analysis”

    HumansFully adjusted continuous analysis, per 1-standard deviation increasen = 1,467

    Triglyceride-glucose-body mass index as an integrated marker for ultrasound-defined diastolic dysfunction: variable importance via machine learning and SHAP analysis in a Chinese community cohort

    Frontiers in cardiovascular medicine

More on Ultrasound-defined diastolic dysfunction

Associations

42

Cardiovascular disease

upin humans5HR 1.06–1.69

5 studies
  1. Triglyceride-glucose body mass index is associated with cardiovascular disease in humans (Without cardiovascular disease at baseline; per 10-unit increase in TyG-BMI) (HR 1.06, 95% CI 1.04–1.07 per 10-unit increase).

    “a 10-unit increase in TyG-BMI corresponded to a 6% higher risk (HR 1.06, 95% CI 1.04-1.07, p < 0.001)”

    HumansWithout cardiovascular disease at baseline; per 10-unit increase in TyG-BMI9 yearsn = 8,104

    Comparison of novel nutritional index (TCBI) and insulin resistance index (TyG-BMI) for assessing cardiovascular disease risk: a cohort study

    Journal of health, population, and nutrition

  2. Triglyceride-glucose body mass index is linked with a higher risk of cardiovascular disease in humans (participants with high TyG-BMI and high hsCRP vs low TyG-BMI and low hsCRP) (HR: 1.38, 95% CI: 1.18-1.62, P < 0.001).

    “Participants in the high TyG-BMI and high hsCRP group demonstrated a substantially higher risk of CVD (HR: 1.38, 95% CI: 1.18-1.62, P < 0.001)”

    Humansparticipants with high TyG-BMI and high hsCRP vs low TyG-BMI and low hsCRPn = 6,534

    Combining triglyceride glucose-body mass index and high-sensitivity C-reactive protein to predict cardiovascular disease: results from a national cohort and a clinical verified cohort

    Frontiers in cardiovascular medicine

  3. Triglyceride-glucose body mass index predicts cardiovascular disease in humans (postmenopausal women aged ≥45 years) (AUC = 0.645 vs 0.622).

    “For CVD prediction, TyG-BMI (AUC = 0.645) outperformed TyG (AUC = 0.622).”

    Humanspostmenopausal women aged ≥45 yearsfemalesn = 2,405

    Link between triglyceride-glucose-body mass index and future cardiovascular disease risk in Chinese menopausal women: A nationwide prospective cohort study

    Experimental gerontology

  4. Triglyceride-glucose body mass index is linked with a higher risk of cardiovascular disease in humans (postmenopausal women aged ≥45 years) (OR = 1.28; 95 % CI: 1.07-1.53).

    “Each interquartile TyG-BMI (49.10) increase raised CVD risk by 28 % (OR = 1.28; 95 % CI: 1.07-1.53).”

    Humanspostmenopausal women aged ≥45 yearsfemalesn = 2,405

    Link between triglyceride-glucose-body mass index and future cardiovascular disease risk in Chinese menopausal women: A nationwide prospective cohort study

    Experimental gerontology

  5. Triglyceride-glucose body mass index is linked with a higher risk of cardiovascular disease in humans (OR = 1.39, 95% CI 1.06-1.82).

    “In the fully adjusted model, the increased odds of CVD for Q4 relative to Q3 was 39% (OR = 1.39, 95% CI 1.06-1.82, P = 0.019).”

    Humansfemalesn = 6,343

    Nonlinear relationships between the triglyceride glucose-body mass index and cardiovascular disease in middle-aged and elderly women from NHANES (1999-2018)

    Scientific reports

  6. Triglyceride-glucose body mass index is linked with a higher risk of cardiovascular disease in humans (HR 1.69, 95% CI 1.44-2.00).

    “higher TyG-BMI levels were associated with an increased risk of CVDs, The hazard ratio (HR) and 95% confidence interval (95% CI) for the highest quartile group were 1.69 (1.44-2.00)”

    Humansaverage follow-up of 7.1 yearsn = 7,072

    Relationship between triglyceride glucose-body mass index baselines and variation with future cardiovascular diseases risk in the middle-aged and elderly individuals

    Frontiers in endocrinology

More on Cardiovascular disease

Cardiometabolic multimorbidity

upin humans3OR 1.61–5.72

3 studies
  1. Triglyceride-glucose body mass index is associated with cardiometabolic multimorbidity in humans (CHARLS; highest versus lowest TyG-BMI quartile; fully adjusted logistic model) (OR 5.72, 95% CI 4.52–7.22).

    “the highest versus lowest TyG-BMI quartile was associated with higher odds of CMM in CHARLS (OR = 5.72, 95% CI 4.52–7.22)”

    HumansCHARLS; highest versus lowest TyG-BMI quartile; fully adjusted logistic modeln = 6,426

    Triglyceride glucose body mass index and incident cardiometabolic multimorbidity among middle and older adults in China and England

    Scientific reports

  2. Triglyceride-glucose body mass index is associated with cardiometabolic multimorbidity in humans (Chinese adults with one cardiometabolic disease at baseline) (Q4 versus Q1: HR 1.895, 95% CI 1.574–2.282; per 1-SD increase: HR 1.315, 95% CI 1.232–1.404).

    “Higher TyG-BMI was associated with an increased hazard of incident FCMD among participants without CMD at baseline and incident CMM among those with one CMD at baseline.”

    HumansChinese adults with one cardiometabolic disease at baselineHighest quartile versus lowest quartileMedian follow-up: 7.0 yearsn = 2,256

    Association Between Triglyceride-Glucose-Body Mass Index and Cardiometabolic Multimorbidity Risk in Middle-Aged and Older Chinese Adults

    Healthcare (Basel, Switzerland)

  3. Triglyceride-glucose body mass index is associated with cardiometabolic multimorbidity in humans (Per standard deviation increase in TyG-BMI) (Adjusted OR 1.61 per standard deviation (95% CI 1.48–1.73); 5.67-fold higher risk in highest versus lowest quartiles).

    “TyG-BMI demonstrated the strongest association with CMM risk, showing a 1.61-fold increase per standard deviation (adjusted OR: 1.61; 95% CI: 1.48-1.73)”

    HumansPer standard deviation increase in TyG-BMI

    Association between triglyceride-glucose derived indices with cardiometabolic multimorbidity: Findings from the Atherosclerosis Risk in Communities study

    PloS one

More on Cardiometabolic multimorbidity

Sarcopenia

upin humans2OR 8.83–9.08

2 studies
  1. Triglyceride-glucose body mass index predicts sarcopenia in humans (AUC 0.738, 95% CI 0.714-0.761 vs AIP AUC 0.648, 95% CI 0.622-0.673).

    “ROC curves showed that TyG-BMI (AUC:0.738, 95% CI: 0.714 - 0.761) was more useful than AIP (AUC:0.648, 95% CI: 0.622 - 0.673) in diagnosing sarcopenia.”

    Humans

    Association of atherogenic index of plasma and triglyceride glucose-body mass index and sarcopenia in adults from 20 to 59: a cross-sectional study

    Frontiers in endocrinology

  2. Triglyceride-glucose body mass index is linked with a higher risk of sarcopenia in humans (OR 8.83, 95% CI 5.46-14.26).

    “Similarly, TyG-BMI and sarcopenia were positively associated with an OR of 8.83 and a 95% CI of (5.46, 14.26).”

    Humans

    Association of atherogenic index of plasma and triglyceride glucose-body mass index and sarcopenia in adults from 20 to 59: a cross-sectional study

    Frontiers in endocrinology

  3. Triglyceride-glucose body mass index is associated with sarcopenia in humans (Q4 vs Q1) (OR = 9.08, 95% CI [2.91-28.37]).

    “The TyG-BMI index demonstrated a stronger association, with the strength of this association increasing significantly as the quartile level rose”

    ReviewQ4 vs Q1n = 82,798

    Association between triglyceride-glucose index and sarcopenia: a meta-analysis

    PeerJ

More on Sarcopenia

Mortality

upin humans2downin humans1HR 0.77–2.79

2 studies
  1. Triglyceride-glucose body mass index is linked with a higher risk of mortality in humans (TyG-BMI above threshold of 289) (HR 1.28, 95% CI 1.13-1.46).

    “Above the threshold of 289, higher TyG-BMI was associated with higher mortality risk: per SD increase HR = 1.28 (95% CI 1.13-1.46, P = 0.0002).”

    HumansTyG-BMI above threshold of 289femalesn = 3,844

    Nonlinear association of triglyceride-glucose body mass index with all-cause mortality in postmenopausal women, a retrospective cohort study: Evidence from the 2001 to 2014 National Health and nutrition examination survey

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

  2. Triglyceride-glucose body mass index is linked with a lower risk of mortality in humans (TyG-BMI below threshold of 289) (HR 0.77, 95% CI 0.69-0.86).

    “Below this point, higher TyG-BMI was associated with lower mortality risk: for each 1 SD (67.0-unit) increase in TyG-BMI, the adjusted HR for all-cause mortality was 0.77 (95% confidence interval [CI] 0.69-0.86, P < 0.0001).”

    HumansTyG-BMI below threshold of 289femalesn = 3,844

    Nonlinear association of triglyceride-glucose body mass index with all-cause mortality in postmenopausal women, a retrospective cohort study: Evidence from the 2001 to 2014 National Health and nutrition examination survey

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

  3. Triglyceride-glucose body mass index is associated with mortality in humans (Patients with osteoporosis; fourth versus first TyG-BMI quartile) (HR 2.79, 95% CI 1.16–6.73).

    “Patients in the fourth quartile (Q4) have an almost 2.8-fold increased risk of all-cause mortality compared to those in the first quartile (Q1)”

    HumansPatients with osteoporosis; fourth versus first TyG-BMI quartilen = 302

    Association between triglyceride glucose-body mass index with all-cause and cardiovascular mortality in adults with osteoporosis: a prospective study

    Frontiers in endocrinology

Cardiovascular mortality

upin humans2HR 2.1–6.33

2 studies
  1. Triglyceride-glucose body mass index is associated with cardiovascular mortality in humans (Third versus first tertile: HR 2.10 (95% CI, 1.14-3.87); second versus first: HR 2.22 (95% CI, 1.17-4.22)).

    “Higher TyG-BMI was associated with increased CV mortality in patients undergoing PD.”

    HumansPatients initiating peritoneal dialysis; third versus first baseline TyG-BMI tertile; fully adjusted Cox modeln = 537

    Baseline Triglyceride-Glucose-Body Mass Index Is Positively Associated With Cardiovascular Mortality in Patients Initiating Peritoneal Dialysis: A Retrospective Cohort Study

    Frontiers in nutrition

  2. Triglyceride-glucose body mass index is associated with cardiovascular mortality in humans (Patients with osteoporosis; fourth TyG-BMI quartile) (HR 6.33, 95% CI 1.19–33.80).

    “The cardiovascular mortality rate is significantly higher in the TyG-BMI Q4 group (HR = 6.33, 95% CI: 1.19-33.80).”

    HumansPatients with osteoporosis; fourth TyG-BMI quartilen = 302

    Association between triglyceride glucose-body mass index with all-cause and cardiovascular mortality in adults with osteoporosis: a prospective study

    Frontiers in endocrinology

Circadian syndrome

upin humans2

2 studies
  1. Triglyceride-glucose body mass index is associated with circadian syndrome in humans (Chinese population).

    “This study provides important evidence that TyG, TyG-BMI, TyG-WC, and TyG-WHtR are significant risk factors for CircS.”

    HumansChinese population4 years

    Association of triglyceride-glucose and its related indices with circadian syndrome: Evidence from a prospective cohort study

    Medicine

  2. Triglyceride-glucose body mass index is linked with a higher risk of circadian syndrome in humans (fully adjusted).

    “TyG-BMI, METS-IR, and AIP were positively associated with CircS risk in both analyses.”

    Humansfully adjustedn = 8,392

    Insulin resistance indices for predicting circadian syndrome: estimated glucose disposal rate as a protective indicator through non-linear dose-response in Chinese adults

    Frontiers in nutrition

More on Circadian syndrome

Osteoporosis

upin humans2OR 1.55

2 studies
  1. Triglyceride-glucose body mass index is associated with osteoporosis in humans After adjustment for potential confounders (OR 1.55; P < 0.05).

    “TyG-BMI, AVI, BRI, and BAI were positively associated with osteoporosis classification”

    HumansAfter adjustment for potential confoundersmalesn = 702

    Associations and potential utility of composite obesity and metabolic indices for osteoporosis risk assessment in Chinese adult men: a cross-sectional study

    BMC musculoskeletal disorders

  2. Triglyceride-glucose body mass index is associated with osteoporosis in humans (Highest versus lowest TyG-BMI quartile; fully adjusted model) (HR 3.67, 95% CI 2.80–4.80).

    “In fully-adjusted models, Q4 had a 3.67-fold higher osteoporosis risk vs. Q1 (95% CI: 2.80-4.80; P < 0.001).”

    HumansHighest versus lowest TyG-BMI quartile; fully adjusted model4-year median follow-upn = 23,930

    Association of triglyceride glucose body mass index with osteoporosis risks in a large Chinese adult cohort

    Frontiers in endocrinology

More on Osteoporosis

Diabetic kidney disease

upin humans2OR 1.019

2 studies
  1. Triglyceride-glucose body mass index is associated with diabetic kidney disease in humans (type 2 diabetes mellitus).

    “Higher quartiles of TyG, TyG-BMI, and TG/HDL-C were significantly associated with increased DKD risk (trend P < 0.001).”

    Humanstype 2 diabetes mellitusn = 311

    The predictive potential of surrogate indicators of insulin resistance for type 2 diabetic kidney disease

    Frontiers in endocrinology

  2. Triglyceride-glucose body mass index is linked with a higher risk of diabetic kidney disease in T2DM patients (OR 1.019, 95% CI: 1.1007-1.030, P = 0.002).

    “TyG-BMI (OR 1.019, 95% CI: 1.1007-1.030, P = 0.002) were independent risk factors for the occurrence of DKD in T2DM”

    Humansin T2DM patients

    Development and validation of a model that predicts the risk of diabetic kidney disease in type 2 diabetes mellitus patients: a retrospective study

    Frontiers in endocrinology

More on Diabetic kidney disease

Diabetes mellitus

upin humans2OR 5.28

2 studies
  1. Triglyceride-glucose body mass index is associated with diabetes mellitus in middle-aged and older adults at high cardiovascular risk, Q4 vs Q1 (OR 5.28 (95% CI: 3.23-8.64)).

    “TyG-BMI was 5.28 (95% CI: 3.23-8.64)”

    Humansin middle-aged and older adults at high cardiovascular risk, Q4 vs Q1

    Association of novel obesity-related lipid markers with diabetes prevalence in high-risk middle-aged and older adults with cardiovascular diseases

    Frontiers in public health

  2. Triglyceride-glucose body mass index is linked with a higher risk of diabetes mellitus in humans (class 2 vs class 1) (HR 1.474).

    “Compared to individuals with consistently low TyG-BMI (class 1), hazard ratios (HRs) for DM were 1.474, 2.250, and 3.142 for participants with moderately sustained and slowly increasing TyG-BMI (class 2)”

    Humansclass 2 vs class 1

    The relationship between longitudinal changes in triglyceride-glucose-body mass index and new-onset diabetes in middle-aged and elderly adults: Evidence from a nationwide Chinese cohort study

    Diabetes research and clinical practice

More on Diabetes mellitus

Early vascular aging

upin humans1OR 1.149

1 study
  1. Triglyceride-glucose body mass index predicts early vascular aging in humans (fully adjusted model incorporating TyG-BMI) (AUC 0.8533).

    “In the fully adjusted model incorporating TyG-BMI, the area under the curve (AUC) for identifying EVA was 0.8533.”

    Humansfully adjusted model incorporating TyG-BMI

    Association between the triglyceride-glucose-body mass index and the risk of early vascular aging in young and middle-aged Chinese adults: a cross-sectional study

    BMC cardiovascular disorders

  2. Triglyceride-glucose body mass index is linked with a higher risk of early vascular aging in humans after full adjustment (OR 1.149, 95% CI 1.083~1.231).

    “each 10-unit increase in TyG-BMI was associated with a 14.9% increased risk of EVA (odds ratio [OR] 1.149, 95% confidence interval [CI] 1.083~1.231).”

    Humansafter full adjustmenteach 10-unit increase

    Association between the triglyceride-glucose-body mass index and the risk of early vascular aging in young and middle-aged Chinese adults: a cross-sectional study

    BMC cardiovascular disorders

All 42

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies associate higher triglyceride-glucose body mass index with increased prediabetes and early vascular aging risk after adjustment. A fully adjusted model incorporating this index predicts early vascular aging.

  2. Summary written from the findings.

Latest

Dec 2025: 5Jan 2026: 10Feb 2026: 5Mar 2026: 4Apr 2026: 1May 2026: 1Jun 2026: 2Jul 2026: 1Aug 2026: 4Sep 2026: 6Oct 2026: 12Nov 2026: 657 papers in 12 months

See all 76 papers on triglyceride-glucose body mass index